The role of obesity in renal cell carcinoma patients: Clinical-pathological implications

Gaetano Aurilio, Francesco Piva, Matteo Santoni, Alessia Cimadamore, Giulia Sorgentoni, Antonio Lopez-Beltran, Liang Cheng, Nicola Battelli, Franco Nolè, Rodolfo Montironi

Research output: Contribution to journalReview article

Abstract

Obesity is a well-known risk factor for renal cell carcinoma (RCC) development. However, the RCC–obesity link has not been fully addressed when considering a comprehensive scenario starting from pathogenetic aspects through pathological issues up to the outcome of medical treatment. We therefore conducted an electronic PubMed search using keywords “obesity”, “body mass index”, “overweight”, “renal cell carcinoma/kidney cancer”, “medical treatment”, “targeted therapy”, and “immunotherapy/immune checkpoint inhibitors”. The selected data supported a crosstalk between adipose tissue (adipocytes and other white adipose tissue cells) and cancer cells inducing several signaling pathways that finally stimulated angiogenesis, survival, and cellular proliferation. Accurate sampling of renal sinus fat correlated with a prognostic value. Retrospective clinical evidence in metastatic RCC patients with higher body mass index (BMI) and treated with targeted therapies and/or immune checkpoint inhibitors showed advantageous survival outcomes. Therefore, obesity may influence the course of RCC patients, although the interplay between obesity/BMI and RCC warrants a large prospective confirmation. We are therefore still far from determining a clear role of obesity as a prognostic/predictive factor in metastatic RCC patients undergoing targeted therapy and immunotherapy.

Original languageEnglish (US)
Article number5683
JournalInternational journal of molecular sciences
Volume20
Issue number22
DOIs
StatePublished - Nov 2019

Fingerprint

obesity
Renal Cell Carcinoma
Obesity
cancer
Cells
Tissue
Body Mass Index
adipose tissues
Crosstalk
Oils and fats
therapy
Immunotherapy
Fats
inhibitors
Sampling
White Adipose Tissue
Survival
Kidney Neoplasms
Therapeutics
sinuses

Keywords

  • Body mass index
  • Clinical outcomes
  • Immunotherapy
  • Obesity
  • Renal cell carcinoma
  • Targeted therapy

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Aurilio, G., Piva, F., Santoni, M., Cimadamore, A., Sorgentoni, G., Lopez-Beltran, A., ... Montironi, R. (2019). The role of obesity in renal cell carcinoma patients: Clinical-pathological implications. International journal of molecular sciences, 20(22), [5683]. https://doi.org/10.3390/ijms20225683

The role of obesity in renal cell carcinoma patients : Clinical-pathological implications. / Aurilio, Gaetano; Piva, Francesco; Santoni, Matteo; Cimadamore, Alessia; Sorgentoni, Giulia; Lopez-Beltran, Antonio; Cheng, Liang; Battelli, Nicola; Nolè, Franco; Montironi, Rodolfo.

In: International journal of molecular sciences, Vol. 20, No. 22, 5683, 11.2019.

Research output: Contribution to journalReview article

Aurilio, G, Piva, F, Santoni, M, Cimadamore, A, Sorgentoni, G, Lopez-Beltran, A, Cheng, L, Battelli, N, Nolè, F & Montironi, R 2019, 'The role of obesity in renal cell carcinoma patients: Clinical-pathological implications', International journal of molecular sciences, vol. 20, no. 22, 5683. https://doi.org/10.3390/ijms20225683
Aurilio, Gaetano ; Piva, Francesco ; Santoni, Matteo ; Cimadamore, Alessia ; Sorgentoni, Giulia ; Lopez-Beltran, Antonio ; Cheng, Liang ; Battelli, Nicola ; Nolè, Franco ; Montironi, Rodolfo. / The role of obesity in renal cell carcinoma patients : Clinical-pathological implications. In: International journal of molecular sciences. 2019 ; Vol. 20, No. 22.
@article{504c2aaff00e4c40b6a992f67554d591,
title = "The role of obesity in renal cell carcinoma patients: Clinical-pathological implications",
abstract = "Obesity is a well-known risk factor for renal cell carcinoma (RCC) development. However, the RCC–obesity link has not been fully addressed when considering a comprehensive scenario starting from pathogenetic aspects through pathological issues up to the outcome of medical treatment. We therefore conducted an electronic PubMed search using keywords “obesity”, “body mass index”, “overweight”, “renal cell carcinoma/kidney cancer”, “medical treatment”, “targeted therapy”, and “immunotherapy/immune checkpoint inhibitors”. The selected data supported a crosstalk between adipose tissue (adipocytes and other white adipose tissue cells) and cancer cells inducing several signaling pathways that finally stimulated angiogenesis, survival, and cellular proliferation. Accurate sampling of renal sinus fat correlated with a prognostic value. Retrospective clinical evidence in metastatic RCC patients with higher body mass index (BMI) and treated with targeted therapies and/or immune checkpoint inhibitors showed advantageous survival outcomes. Therefore, obesity may influence the course of RCC patients, although the interplay between obesity/BMI and RCC warrants a large prospective confirmation. We are therefore still far from determining a clear role of obesity as a prognostic/predictive factor in metastatic RCC patients undergoing targeted therapy and immunotherapy.",
keywords = "Body mass index, Clinical outcomes, Immunotherapy, Obesity, Renal cell carcinoma, Targeted therapy",
author = "Gaetano Aurilio and Francesco Piva and Matteo Santoni and Alessia Cimadamore and Giulia Sorgentoni and Antonio Lopez-Beltran and Liang Cheng and Nicola Battelli and Franco Nol{\`e} and Rodolfo Montironi",
year = "2019",
month = "11",
doi = "10.3390/ijms20225683",
language = "English (US)",
volume = "20",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "22",

}

TY - JOUR

T1 - The role of obesity in renal cell carcinoma patients

T2 - Clinical-pathological implications

AU - Aurilio, Gaetano

AU - Piva, Francesco

AU - Santoni, Matteo

AU - Cimadamore, Alessia

AU - Sorgentoni, Giulia

AU - Lopez-Beltran, Antonio

AU - Cheng, Liang

AU - Battelli, Nicola

AU - Nolè, Franco

AU - Montironi, Rodolfo

PY - 2019/11

Y1 - 2019/11

N2 - Obesity is a well-known risk factor for renal cell carcinoma (RCC) development. However, the RCC–obesity link has not been fully addressed when considering a comprehensive scenario starting from pathogenetic aspects through pathological issues up to the outcome of medical treatment. We therefore conducted an electronic PubMed search using keywords “obesity”, “body mass index”, “overweight”, “renal cell carcinoma/kidney cancer”, “medical treatment”, “targeted therapy”, and “immunotherapy/immune checkpoint inhibitors”. The selected data supported a crosstalk between adipose tissue (adipocytes and other white adipose tissue cells) and cancer cells inducing several signaling pathways that finally stimulated angiogenesis, survival, and cellular proliferation. Accurate sampling of renal sinus fat correlated with a prognostic value. Retrospective clinical evidence in metastatic RCC patients with higher body mass index (BMI) and treated with targeted therapies and/or immune checkpoint inhibitors showed advantageous survival outcomes. Therefore, obesity may influence the course of RCC patients, although the interplay between obesity/BMI and RCC warrants a large prospective confirmation. We are therefore still far from determining a clear role of obesity as a prognostic/predictive factor in metastatic RCC patients undergoing targeted therapy and immunotherapy.

AB - Obesity is a well-known risk factor for renal cell carcinoma (RCC) development. However, the RCC–obesity link has not been fully addressed when considering a comprehensive scenario starting from pathogenetic aspects through pathological issues up to the outcome of medical treatment. We therefore conducted an electronic PubMed search using keywords “obesity”, “body mass index”, “overweight”, “renal cell carcinoma/kidney cancer”, “medical treatment”, “targeted therapy”, and “immunotherapy/immune checkpoint inhibitors”. The selected data supported a crosstalk between adipose tissue (adipocytes and other white adipose tissue cells) and cancer cells inducing several signaling pathways that finally stimulated angiogenesis, survival, and cellular proliferation. Accurate sampling of renal sinus fat correlated with a prognostic value. Retrospective clinical evidence in metastatic RCC patients with higher body mass index (BMI) and treated with targeted therapies and/or immune checkpoint inhibitors showed advantageous survival outcomes. Therefore, obesity may influence the course of RCC patients, although the interplay between obesity/BMI and RCC warrants a large prospective confirmation. We are therefore still far from determining a clear role of obesity as a prognostic/predictive factor in metastatic RCC patients undergoing targeted therapy and immunotherapy.

KW - Body mass index

KW - Clinical outcomes

KW - Immunotherapy

KW - Obesity

KW - Renal cell carcinoma

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85075037673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075037673&partnerID=8YFLogxK

U2 - 10.3390/ijms20225683

DO - 10.3390/ijms20225683

M3 - Review article

C2 - 31766196

AN - SCOPUS:85075037673

VL - 20

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 22

M1 - 5683

ER -